Memorial Sloan Kettering Awards and Appointments

Memorial Sloan Kettering Cancer Center (MSK) announces its most recent awards and appointments for the institution’s physicians, scientists, nurses, and staff.

Read more

Offering a Pay-for-Performance Program to Oncology Practices Increases Prescriptions of Evidence-based Cancer Drugs

A pay-for performance program that offers enhanced reimbursement to oncology practices for prescribing high-quality, evidence-based cancer drugs increased use of these drugs without significantly changing total spending on care, Penn Medicine researchers report in a new study published online in the Journal of Clinical Oncology.

Read more

Computational Biologist Thomas Norman of Sloan Kettering Institute Honored with Distinguished NIH Director’s New Innovator Award

Computational biologist Thomas Norman, PhD, of Memorial Sloan Kettering’s (MSK) Sloan Kettering Institute (SKI) has been named one of 53 recipients of the prestigious 2020 National Institutes of Health (NIH) Director’s New Innovator Award. As part of the award, Dr. Norman will receive $1.5 million in direct costs upfront in the first year of a five-year award.

Read more

New tools to improve care for cancer that has spread to the brain

The tools will help doctors and patients make better-informed treatment decisions, enhance the care of brain metastases, and enable hospitals to improve the coordination and effectiveness of their interdisciplinary treatment programs.

Read more

Study Reinforces Benefit Using Targeted Therapy for Early Stage NSCLC

According to updated findings led by researchers at Yale Cancer Center, treatment with the targeted therapy osimertinib following surgery continues to significantly improve disease-free survival (DFS) in patients with early-stage, non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) gene mutations.

Read more

Seattle Cancer Care Alliance Nursing Staff Leads 10 Poster Presentations at Oncology Nursing Society Bridge Virtual Conference

Seattle Cancer Care Alliance (SCCA), committed to delivering patient-centered, high-quality cancer care as the only NCCN-designated cancer center in Washington State, announced that members of its clinical nursing staff will participate in 10 poster presentations during the 2020 Oncology Nursing Society (ONS) Bridge Virtual Conference. The meeting is being held September 8, 10, 15 and 17, 2020.

Read more

Jersey Shore University Medical Center Launches Cardio-Oncology Program

Hackensack Meridian Jersey Shore University Medical Center recently launched a Cardio-Oncology Program providing cancer patients and survivors access to cardiology and oncology specialists and advanced imaging services. L. Steven Zukerman, M.D., FACC, serves as medical director of the program, designed to minimize the impact of cancer treatments on patients’ hearts and provide continuing cardiac care to cancer survivors.

Read more

New Treatment Developed by Children’s Hospital of Philadelphia Shows Success in High-Risk Solid Tumors

In a breakthrough study, researchers at Children’s Hospital of Philadelphia (CHOP) have shown that an enhanced treatment developed in their lab leads to long-term remissions in 80% to 100% of mice with drug-resistant or high-risk solid tumors. The research, which could soon lead to clinical trials, is described in Cancer Research, a journal of the American Association for Cancer Research.

Read more